MauritiusTuberculosis profile
Population  2014 1.3 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.016 (0.016–0.017) 1.3 (1.3–1.3)
Mortality (HIV+TB only) 0.01 (<0.01–0.014) 0.79 (0.54–1.1)
Prevalence  (includes HIV+TB) 0.44 (0.23–0.71) 35 (18–56)
Incidence  (includes HIV+TB) 0.28 (0.24–0.31) 22 (19–24)
Incidence (HIV+TB only) 0.042 (0.036–0.048) 3.3 (2.8–3.8)
         
Case detection, all forms (%) 46 (41–52)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0 (0–3.2) 33 (0.84–91)
MDR-TB cases among notified pulmonary
TB cases
0 (0–4) 1 (0–3)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 114   2
Pulmonary, clinically diagnosed 0   0
Extrapulmonary 10   0
       
Total new and relapse 126    
Previously treated, excluding relapses 1    
Total cases notified 127    
Among 126 new and relapse cases:
0 (0%) cases aged under 15 years; male:female ratio: 2.2
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 114 (100%) 3 (100%) 117
Laboratory-confirmed RR-/MDR-TB cases     1
Patients started on MDR-TB treatment ***     1
TB/HIV 2014 Number (%)
TB patients with known HIV status 122 (96)
HIV-positive TB patients 15 (12)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 15 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 15 (100)
HIV-positive people screened for TB 412  
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (88) 130
Previously treated cases, excluding relapse, registered in 2013   0
HIV-positive TB cases, all types, registered in 2013 (65) 23
RR-/MDR-TB cases started on second-line treatment in 2012   0
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? No
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-08-27 Data: www.who.int/tb/data